Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-27 @ 5:04 AM
Study NCT ID:
NCT01106534
Status:
COMPLETED
Last Update Posted:
2023-11-14
First Post:
2010-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Sponsor:
Abbott Medical Devices
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
06-374C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None